At Quest Diagnostics, we’re committed to helping pharmaceutical and biotech companies bring innovative treatments to market. By harnessing our real-world data, we can help support every stage of the drug development journey—from early research and clinical trials to commercialization and post-market surveillance.
Gain powerful insights from labs, EHR and claims data to fuel IgAN research, clinical trials, and commercialization
Our IgAN data includes key biomarkers and combines data from labs, EHRs, and claims, delivering a comprehensive view of the patient journey. All data is securely tokenized—replacing personally identifiable information with unique tokens to ensure patient privacy and meet regulatory standards. This integrated data combination empowers more informed decisions and accelerates progress across IgAN research and commercialization, without compromising confidentiality.
Our IgAN data includes relevant clinical biomarkers essential for disease discovery, diagnosis, prognosis, therapy selection and monitoring– empower data-driven decision-making throughout the entire drug development lifecycle.
